NCT02620878View on ClinicalTrials.gov

Artificial Pancreas in Pediatric Patients (PEDarPAN)

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Type 1 Diabetes
Interventions
DEVICE

artificial pancreas

Patients will be randomly assigned to receive either 3 days of automated closed-loop insulin delivery (intervention) followed by 3 days of sensor -augmented pump therapy (control), or the inverted sequence.

OTHER

sensor augmented pump

During this control period (comparator arm) the patients will use sensor augmented pump. This period will be compared to the same period of artificial pancreas

Trial Locations (1)

Unknown

University of Padova, Padua

All Listed Sponsors
lead

University of Padova

OTHER

NCT02620878 - Artificial Pancreas in Pediatric Patients (PEDarPAN) | Biotech Hunter | Biotech Hunter